1. Home
  2. CNTB vs ULBI Comparison

CNTB vs ULBI Comparison

Compare CNTB & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • ULBI
  • Stock Information
  • Founded
  • CNTB 2012
  • ULBI 1990
  • Country
  • CNTB United States
  • ULBI United States
  • Employees
  • CNTB N/A
  • ULBI N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • ULBI Industrial Machinery/Components
  • Sector
  • CNTB Health Care
  • ULBI Miscellaneous
  • Exchange
  • CNTB Nasdaq
  • ULBI Nasdaq
  • Market Cap
  • CNTB 114.8M
  • ULBI 128.6M
  • IPO Year
  • CNTB 2021
  • ULBI 1992
  • Fundamental
  • Price
  • CNTB $1.57
  • ULBI $6.85
  • Analyst Decision
  • CNTB Strong Buy
  • ULBI Strong Buy
  • Analyst Count
  • CNTB 2
  • ULBI 1
  • Target Price
  • CNTB $7.50
  • ULBI $14.00
  • AVG Volume (30 Days)
  • CNTB 184.6K
  • ULBI 57.9K
  • Earning Date
  • CNTB 09-05-2025
  • ULBI 11-07-2025
  • Dividend Yield
  • CNTB N/A
  • ULBI N/A
  • EPS Growth
  • CNTB N/A
  • ULBI N/A
  • EPS
  • CNTB N/A
  • ULBI 0.19
  • Revenue
  • CNTB $1,965,000.00
  • ULBI $178,853,000.00
  • Revenue This Year
  • CNTB N/A
  • ULBI $31.30
  • Revenue Next Year
  • CNTB N/A
  • ULBI $6.24
  • P/E Ratio
  • CNTB N/A
  • ULBI $36.17
  • Revenue Growth
  • CNTB N/A
  • ULBI 5.86
  • 52 Week Low
  • CNTB $1.56
  • ULBI $4.07
  • 52 Week High
  • CNTB $2.20
  • ULBI $10.09
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 39.75
  • ULBI 45.30
  • Support Level
  • CNTB $1.63
  • ULBI $6.57
  • Resistance Level
  • CNTB $1.79
  • ULBI $7.39
  • Average True Range (ATR)
  • CNTB 0.18
  • ULBI 0.30
  • MACD
  • CNTB -0.04
  • ULBI 0.04
  • Stochastic Oscillator
  • CNTB 0.39
  • ULBI 34.15

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

Share on Social Networks: